Work

A randomized phase 2 study of trametinib with or without GSK2141795 in patients with advanced uveal melanoma.

Year: 2016

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2016.34.15_suppl.9511

Authors: Alexander Noor Shoushtari, Ragini Reiney Kudchadkar, Katherine Panageas, Rashmi Krishna Murthy, Maria Jung, Roshani Shah, Bridget O'Donnell, Talal T. Khawaja, Yelena Shames, Nana A. Prempeh-Keteku, Grazia Ambrosini, Helen X. Chen, Paul B. Chapman, Gary K. Schwartz, Richard D. Carvajal, Sapna Pradyuman Patel

Institutions: Memorial Sloan Kettering Cancer Center, Emory University, Winship Cancer Institute, The University of Texas MD Anderson Cancer Center, National Cancer Institute, NewYork–Presbyterian Hospital, Columbia University Irving Medical Center

Language: English

Topic: Ocular Oncology and Treatments

Subfield: Ophthalmology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2740604052

Cites:

Cited by: 56

Related to: 10